For the Danish entomologist, see William Lundbeck.
A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page.(September 2022) (Learn how and when to remove this message)
H. Lundbeck A/S
Company type
Aktieselskab
Traded as
Nasdaq Copenhagen: HLUN A Nasdaq Copenhagen: HLUN B
Industry
Pharmaceuticals
Founded
1915; 109 years ago (1915)
Founder
Hans Lundbeck
Headquarters
Copenhagen, Denmark
Key people
Charl van Zyl (CEO,President) Joerg Hornstein (CFO)
[1]
Website
www.lundbeck.com
H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.[2]
Headquartered in Copenhagen, Denmark, Lundbeck has approximately 5,600 employees[3] in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US.[4]
Lundbeck is listed on the Copenhagen Stock Exchange (CSE).[5]
Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
^"Lundbeck replaces retiring CEO Dunsire with UCB exec after breaking sales record". 27 June 2023. Retrieved 2023-06-27.
^"Facts and background". lundbeck.com. Retrieved 2021-04-07.
^"Wayback Machine" (PDF). 2021-06-11. Archived from the original (PDF) on 2021-06-11. Retrieved 2023-01-25.
^"Facts and background". lundbeck.com. Retrieved 2021-04-07.
H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research, development, manufacturing...
The Brain Prize, formerly known as The Grete Lundbeck European Brain Research Prize, is an international scientific award honouring "one or more scientists...
Lundbeck Seattle Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Formerly known as Alder Biopharmaceuticals, it...
(both somnolence and insomnia). Brexpiprazole was developed by Otsuka and Lundbeck, and is considered to be a successor to aripiprazole (Abilify). It was...
was in Phase II clinical trials, and Lundbeck and Takeda entered into a partnership in which Takeda paid Lundbeck $40 million up-front, with promises of...
pharmaceutical company Lundbeck, plus a total of €52.2 million on several generic pharmaceutical-producing companies. This was in response to Lundbeck entering an...
William Lundbeck (16 October 1863 in Aalborg – 18 May 1941 in Kongens Lyngby) was a Danish entomologist mainly interested in Diptera. He was a Professor...
resulting in a series of clinical trials sponsored by Lundbeck and Merck. In March, 2007, Merck and Lundbeck cancelled work on the drug, citing safety concerns...
company Lundbeck. Use of the drug for executions is illegal under Danish law, and when this was discovered, after public outcry in Danish media, Lundbeck stopped...
left and joined Xtuit for one year. Dunsire was appointed as the CEO of Lundbeck, a neuroscience-focused pharmaceutical company based in Denmark, in July...
a potent and selective 5-HT6 receptor antagonist under development by Lundbeck as an augmentation therapy for the treatment of cognitive deficits associated...
treatment for hereditary angioedema. In March 2009, Lundbeck purchased Ovation In 2010, Lundbeck withdrew stanozolol from the market in the US; as of...
at Lundbeck; in 2007 Lundbeck and Takeda entered into a partnership that included tedatioxetine but was focused on another, more advanced Lundbeck drug...
antipsychotic drug of the thioxanthene class. It was introduced in 1965 by Lundbeck. In addition to single drug preparations, it is also available as...
Cymbalta" (PDF). Fraende M (April 22, 2011). "Lundbeck gets Lexapro approval in Japan". Reuters. "Takeda and Lundbeck Submit New Drug Application (NDA) for Vortioxetine...
name: escitalopram. Escitalopram was developed in cooperation between Lundbeck and Forest Laboratories. Its development was initiated in 1997, and the...
pharmaceutical products). 2009 – Ovation was acquired by Lundbeck, which now markets Mebaral. 2012 – Lundbeck announced that they were abandoning the product in...
the Japanese market and with Lundbeck for other markets including Europe; the drug was originally marketed by Lundbeck under the name Ebixa. Sales of...
aripiprazole for children and older people with dementia. In 2011 Otsuka and Lundbeck signed a collaboration to develop a depot formulation of aripiprazole....
"Lundbeck Announces Availability of NORTHERATM (droxidopa) Capsules in the U.S. for Symptomatic Neurogenic Orthostatic Hypotension" (PDF). Lundbeck NA...
companies and academia. Many major Danish companies like Novo Nordisk and Lundbeck, both of which are among the 50 largest pharmaceutical and biotech companies...
livsløb af en grænsepersonlighed forstået gennem hans billeder]. Danmark: Lundbeck Pharma A/S. ISBN 978-87-983524-1-9. Wylie HW (1980). "Edvard Munch". The...
International College of Neuropsychopharmacology honoured Stahl with the Lundbeck Foundation Award in Education for contributions to postgraduate education...
2016. Sertindole ‡ – Developed by the Danish pharmaceutical company H. Lundbeck. Like the other atypical antipsychotics, it is believed to have antagonist...
introduced by Lundbeck in 1961. Clopenthixol is a mixture of cis and trans isomers. Zuclopenthixol, the pure cis isomer, was later introduced by Lundbeck in 1962...
livsløb af en grænsepersonlighed forstået gennem hans billeder]. Danmark: Lundbeck Pharma A/S. ISBN 978-8798352419. Altern, Arne (1961). "Tanker omkring et...
Global Information
